Home - Products - Others - Other Targets - Ophiogenin3-O-α-L-rhamnopyranosyl-(1-2)-β-D-glucopyranoside

Ophiogenin3-O-α-L-rhamnopyranosyl-(1-2)-β-D-glucopyranoside

CAS No. 128502-94-3

Ophiogenin3-O-α-L-rhamnopyranosyl-(1-2)-β-D-glucopyranoside( ——— )

Catalog No. M39513 CAS No. 128502-94-3

Ophiogenin3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 526 In Stock
10MG 754 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ophiogenin3-O-α-L-rhamnopyranosyl-(1-2)-β-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Ophiogenin3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside
  • Description
    Ophiogenin3-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    128502-94-3
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pipercide (Retrofrac...

    The fruits of Piper nigrum L.

  • (Glu2)-TRH

    (Glu2)-TRH, a metabolically stable analogue of Thyrotropin-releasing hormone (TRH), is a negative modulator for the cholinergic effect of TRH in the mouse brain. (Glu2)-TRH significantly attenuates TRH-induced hippocampal extracellular acetylcholine release. (Glu2)-TRH is not metabolized by thyroliberinase. (Glu2)-TRH manifests neuroprotective, antidepressant, anticonvulsant in the CNS.

  • KT-474

    KT-474 (KYM-001) is a PROTAC degrader targeting interleukin-1 receptor-associated kinase 4 (IRAK4) with antitumor activity for the study of autoimmune, inflammatory, and cardiovascular disease disorders.